Products


InvaGen develops products and markets prescription drug medicines at cost-effective affordable prices to consumers that are no longer protected by patents. InvaGen offers more than 28 products with more than 200 SKU’s.

List of Approved Abbreviated New Drug Applications (ANDA’s) filed with USFDA

Application Details Strength
Fosinopril Sodium Tablets USP 10 mg, 20 mg and 40 mg
Glimepiride Tablets 1 mg, 2 mg and 4 mg
Sertraline Hydrochloride Tablets 25 mg, 50 mg and 100 mg
Terbinafine Hydrochloride Tablets 250 mg
Citalopram Hydrobromide Tablets USP 10 mg, 20 mg and 40 mg
Gemfibrozil Tablets USP 600 mg
Zonisamide Capsules 25 mg, 50 mg and 100 mg
Amlodipine Besylate Tablets 2.5 mg, 5 mg and 10 mg
Zolpidem Tartrate Tablets 5 mg and 10 mg
Levetiracetam Tablets 250 mg, 500 mg and 750 mg
Trandolapril Tablets 1 mg, 2 mg and 4 mg
Quinapril Hydrochloride Tablets, USP 5 mg, 10 mg, 20 mg and 40 mg
Meprobamate Tablets USP 200 mg and 400 mg
Hydroxyzine HCl Tablets USP 10 mg, 25 mg and 50 mg
Nabumetone Tablets USP 500 mg and 750 mg
Ramipril Capsules 1.25 mg, 2.5 mg, 5 mg, and 10mg
Topiramate Tablets 25 mg, 50 mg, 100 mg and 200 mg
Folic Acid Tablets USP 1 mg
HydrALAzine HCl Tablets USP 10 mg, 25 mg, 50 mg and 100 mg
Fosinopril Sodium and
Hydrochlorthaizide Tablets USP
10/12.5 mg and 20/12.5 mg
Gabapentin Capsules USP 100 mg, 300 mg and 400 mg
Benztropine Mesylate Tablets, USP 0.5 mg, 1 mg and 2 mg
Carbinoxamine Maleate Tablets USP 4 mg
Cyclobenzaprine HCl Tablets USP 5 mg and 10 mg
Quinapril HCl and Hydrochlorothiazide Tablets 10/12.5 mg, 20/12.5 mg and 20/25 mg
Warfarin Sodium Tablets USP 1 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg and 10 mg
Naproxen Tablets USP 250 mg, 375 mg and 500 mg
Naproxen Delayed-release Tablets USP 375 mg and 500 mg